Endothelial monocyte-activating polypeptide II: A novel tumor-derived polypeptide that activates host-response mechanisms

Janet Kao, Jane Ryan, Gerold Brett, Jingxian Chen, Hong Shen, Yan G. Fan, Gabriel Godman, Philip C. Familletti, Feng Wang, Yu Ching E Pan, David Stern, Matthias Clauss

Research output: Contribution to journalArticle

159 Citations (Scopus)

Abstract

An important means by which tumor cells influence the vasculature is through the production of soluble mediators altering vascular properties. A ≈22-kDa polypeptide was purified to homogeneity from conditioned medium of murine methylcholanthrene A (meth A) fibrosarcoma cells by ion-exchange chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), based on its ability to induce tissue factor procoagulant activity in endothelial cells (ECs). The final product migrated as a broad band on reduced and nonreduced SDS-PAGE and had an unique amino-terminal sequence. This meth A-derived polypeptide modulated EC coagulant properties through the induction of tissue factor, induced monocyte migration and tissue factor expression, and was also chemotactic for granulocytes. Injection of the polypeptide into mouse footpads resulted in an inflammatory response with tissue swelling and polymorphonuclear leukocyte infiltration. The ability of this mediator to activate ECs and monocytes has led us to name it EMAP II (endothelial monocyte-activating golypeptide). EMAP II is distinct from a previously described ≈40-kDa meth A-derived polypeptide termed EMAP I. Through its potential to activate host effector mechanisms, EMAP II could contribute to the biology of immunogenic tumors, such as the meth A fibrosarcoma.

Original languageEnglish (US)
Pages (from-to)20239-20247
Number of pages9
JournalJournal of Biological Chemistry
Volume267
Issue number28
StatePublished - Oct 5 1992
Externally publishedYes

Fingerprint

Methylcholanthrene
Tumors
Endothelial cells
Thromboplastin
Monocytes
Peptides
Endothelial Cells
Fibrosarcoma
Electrophoresis
Sodium Dodecyl Sulfate
Polyacrylamide Gel Electrophoresis
Neoplasms
Coagulants
Ion Exchange Chromatography
Conditioned Culture Medium
Chromatography
Infiltration
Granulocytes
Names
Blood Vessels

ASJC Scopus subject areas

  • Biochemistry

Cite this

Endothelial monocyte-activating polypeptide II : A novel tumor-derived polypeptide that activates host-response mechanisms. / Kao, Janet; Ryan, Jane; Brett, Gerold; Chen, Jingxian; Shen, Hong; Fan, Yan G.; Godman, Gabriel; Familletti, Philip C.; Wang, Feng; Pan, Yu Ching E; Stern, David; Clauss, Matthias.

In: Journal of Biological Chemistry, Vol. 267, No. 28, 05.10.1992, p. 20239-20247.

Research output: Contribution to journalArticle

Kao, J, Ryan, J, Brett, G, Chen, J, Shen, H, Fan, YG, Godman, G, Familletti, PC, Wang, F, Pan, YCE, Stern, D & Clauss, M 1992, 'Endothelial monocyte-activating polypeptide II: A novel tumor-derived polypeptide that activates host-response mechanisms', Journal of Biological Chemistry, vol. 267, no. 28, pp. 20239-20247.
Kao, Janet ; Ryan, Jane ; Brett, Gerold ; Chen, Jingxian ; Shen, Hong ; Fan, Yan G. ; Godman, Gabriel ; Familletti, Philip C. ; Wang, Feng ; Pan, Yu Ching E ; Stern, David ; Clauss, Matthias. / Endothelial monocyte-activating polypeptide II : A novel tumor-derived polypeptide that activates host-response mechanisms. In: Journal of Biological Chemistry. 1992 ; Vol. 267, No. 28. pp. 20239-20247.
@article{ca166d1138b94c7692e9d3b9b7c80c55,
title = "Endothelial monocyte-activating polypeptide II: A novel tumor-derived polypeptide that activates host-response mechanisms",
abstract = "An important means by which tumor cells influence the vasculature is through the production of soluble mediators altering vascular properties. A ≈22-kDa polypeptide was purified to homogeneity from conditioned medium of murine methylcholanthrene A (meth A) fibrosarcoma cells by ion-exchange chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), based on its ability to induce tissue factor procoagulant activity in endothelial cells (ECs). The final product migrated as a broad band on reduced and nonreduced SDS-PAGE and had an unique amino-terminal sequence. This meth A-derived polypeptide modulated EC coagulant properties through the induction of tissue factor, induced monocyte migration and tissue factor expression, and was also chemotactic for granulocytes. Injection of the polypeptide into mouse footpads resulted in an inflammatory response with tissue swelling and polymorphonuclear leukocyte infiltration. The ability of this mediator to activate ECs and monocytes has led us to name it EMAP II (endothelial monocyte-activating golypeptide). EMAP II is distinct from a previously described ≈40-kDa meth A-derived polypeptide termed EMAP I. Through its potential to activate host effector mechanisms, EMAP II could contribute to the biology of immunogenic tumors, such as the meth A fibrosarcoma.",
author = "Janet Kao and Jane Ryan and Gerold Brett and Jingxian Chen and Hong Shen and Fan, {Yan G.} and Gabriel Godman and Familletti, {Philip C.} and Feng Wang and Pan, {Yu Ching E} and David Stern and Matthias Clauss",
year = "1992",
month = "10",
day = "5",
language = "English (US)",
volume = "267",
pages = "20239--20247",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "28",

}

TY - JOUR

T1 - Endothelial monocyte-activating polypeptide II

T2 - A novel tumor-derived polypeptide that activates host-response mechanisms

AU - Kao, Janet

AU - Ryan, Jane

AU - Brett, Gerold

AU - Chen, Jingxian

AU - Shen, Hong

AU - Fan, Yan G.

AU - Godman, Gabriel

AU - Familletti, Philip C.

AU - Wang, Feng

AU - Pan, Yu Ching E

AU - Stern, David

AU - Clauss, Matthias

PY - 1992/10/5

Y1 - 1992/10/5

N2 - An important means by which tumor cells influence the vasculature is through the production of soluble mediators altering vascular properties. A ≈22-kDa polypeptide was purified to homogeneity from conditioned medium of murine methylcholanthrene A (meth A) fibrosarcoma cells by ion-exchange chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), based on its ability to induce tissue factor procoagulant activity in endothelial cells (ECs). The final product migrated as a broad band on reduced and nonreduced SDS-PAGE and had an unique amino-terminal sequence. This meth A-derived polypeptide modulated EC coagulant properties through the induction of tissue factor, induced monocyte migration and tissue factor expression, and was also chemotactic for granulocytes. Injection of the polypeptide into mouse footpads resulted in an inflammatory response with tissue swelling and polymorphonuclear leukocyte infiltration. The ability of this mediator to activate ECs and monocytes has led us to name it EMAP II (endothelial monocyte-activating golypeptide). EMAP II is distinct from a previously described ≈40-kDa meth A-derived polypeptide termed EMAP I. Through its potential to activate host effector mechanisms, EMAP II could contribute to the biology of immunogenic tumors, such as the meth A fibrosarcoma.

AB - An important means by which tumor cells influence the vasculature is through the production of soluble mediators altering vascular properties. A ≈22-kDa polypeptide was purified to homogeneity from conditioned medium of murine methylcholanthrene A (meth A) fibrosarcoma cells by ion-exchange chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), based on its ability to induce tissue factor procoagulant activity in endothelial cells (ECs). The final product migrated as a broad band on reduced and nonreduced SDS-PAGE and had an unique amino-terminal sequence. This meth A-derived polypeptide modulated EC coagulant properties through the induction of tissue factor, induced monocyte migration and tissue factor expression, and was also chemotactic for granulocytes. Injection of the polypeptide into mouse footpads resulted in an inflammatory response with tissue swelling and polymorphonuclear leukocyte infiltration. The ability of this mediator to activate ECs and monocytes has led us to name it EMAP II (endothelial monocyte-activating golypeptide). EMAP II is distinct from a previously described ≈40-kDa meth A-derived polypeptide termed EMAP I. Through its potential to activate host effector mechanisms, EMAP II could contribute to the biology of immunogenic tumors, such as the meth A fibrosarcoma.

UR - http://www.scopus.com/inward/record.url?scp=0026781869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026781869&partnerID=8YFLogxK

M3 - Article

C2 - 1400342

AN - SCOPUS:0026781869

VL - 267

SP - 20239

EP - 20247

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 28

ER -